Exelixis
EXEL
#1827
Rank
$11.69 B
Marketcap
$43.63
Share price
-1.20%
Change (1 day)
18.40%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company